Niftify.in: Live Stock Market Data, Stock News, Analysis & Investing in India

Latest Gland Pharma News

Gland Pharma Stock News and Insights: Stay updated with the latest Gland Pharma stock news and industry trends. Access quick information on Gland Pharma stock buybacks,Gland Pharma results, Gland Pharma company analysis, Gland Pharma live prices, Gland Pharma dividends, Gland Pharma bonus share, board meetings, lifetime highs, Gland Pharma targets, lows, and growth stories with AI—all in one place.

Drug maker Lupin has signed a distribution agreement with Ireland-based Scope Ophthalmics to market the Optase range of eye care products in Mexico, aimed at treating conditions like dry eyes, blepharitis, and meibomian gland dysfunction. This deal enhances Lupin’s ophthalmology portfolio while expanding Scope’s presence in Latin America, emphasizing their commitment to improving vision care.

The Economic Times

Lupin ties up with Scope Opthalmics to market eyecare products in Mexico

Drug maker Lupin has signed a distribution agreement with Ireland-based Scope Ophthalmics to market the Optase range of eye care products in Mexico, aimed at treating conditions like dry eyes, blepharitis, and meibomian gland dysfunction. This deal enhances Lupin’s ophthalmology portfolio while expanding Scope’s presence in Latin America, emphasizing their commitment to improving vision care.

•

Mon, Sep 30, 2024

Easy Trip Planners Ltd, BF Utilities Ltd, Gland Pharma Ltd and One 97 Communications Ltd are among the other losers in the BSE's 'A' group today, 27 September 2024.

Business Standard

Home First Finance Company India Ltd leads losers in 'A' group

Easy Trip Planners Ltd, BF Utilities Ltd, Gland Pharma Ltd and One 97 Communications Ltd are among the other losers in the BSE's 'A' group today, 27 September 2024.

Finance

•

Fri, Sep 27, 2024

Goldman Sachs is anticipating Gland Pharma's profitability to face headwinds. It has highlighted five factors as to why it believes so.

CNBC TV18

Goldman Sachs expects Gland Pharma shares to fall back to their IPO price

Goldman Sachs is anticipating Gland Pharma's profitability to face headwinds. It has highlighted five factors as to why it believes so.

•

Fri, Sep 27, 2024

Gland Pharma Ltd is quoting at Rs 1936.35, up 1.59% on the day as on 12:49 IST on the NSE. The stock is up 14.9% in last one year as compared to a 24.3% jump in NIFTY and a 50.09% jump in the Nifty Pharma index.

Business Standard

Gland Pharma Ltd gains for third straight session

Gland Pharma Ltd is quoting at Rs 1936.35, up 1.59% on the day as on 12:49 IST on the NSE. The stock is up 14.9% in last one year as compared to a 24.3% jump in NIFTY and a 50.09% jump in the Nifty Pharma index.

•

Mon, Sep 9, 2024

Around 10 companies experienced the largest increase in mutual fund holdings in June 2024

The Economic Times

Gland Pharma, Indus Towers lead top 10 companies with highest increase in MF holdings in June quarter

Around 10 companies experienced the largest increase in mutual fund holdings in June 2024

•

Fri, Aug 9, 2024

The MF holding stood at Rs 39.59 lakh crore as on June, 2024, an increase of 16.49% over the last quarter. Top 10 companies with the highest MF holding in rupee value terms.

The Economic Times

Gland Pharma, Federal Bank among top 10 companies with highest mutual fund holdings in June quarter

The MF holding stood at Rs 39.59 lakh crore as on June, 2024, an increase of 16.49% over the last quarter. Top 10 companies with the highest MF holding in rupee value terms.

•

Thu, Aug 8, 2024

Business Line

Gland Pharma in talks with a leading biologics player for tie-up

Q1 net down 26 per cent at ₹143.8 crore

•

Tue, Aug 6, 2024

Here is what the charts say about the shares of Gland Pharma, Tata Teleservices (Maharashtra) and Timken India

Business Line

Movers & Shakers: Stocks that will see action this week

Here is what the charts say about the shares of Gland Pharma, Tata Teleservices (Maharashtra) and Timken India

•

Sat, Jul 20, 2024

Stocks News

Sebi approves new asset class for high net worth individuals with riskier appetite

New asset class to have a minimum investment amount of Rs 10 lakh.

WORTH

Block deals: Rs 51 crore worth share purchase in SpiceJet, BofA picks stake in this smallcap

Plutus Wealth Management purchased a significant stake in SpiceJet, buying shares at Rs 59.95 apiece. This was a slight increase from Friday's closing price of Rs 58.99. The stock surged on Monday, closing at Rs 63.70, a gain of 7.98%. This indicates a positive market response to Plutus's investment in the airline.

WEALTH

WORTH

Sebi levies Rs 10 lakh fine on Anand Rathi for violating stock brokers rules

Based on the findings of the inspection, the regulator found certain alleged non-compliances of Stock Brokers regulations and circulars issued by Sebi, NSE and BSE.

BSE

Polycab, Jubilant FoodWorks among 5 stocks with long unwinding

Long unwinding happens when investors sell stocks they've held for a while, either to lock in profits or because they expect the price to drop.

POLYCAB

JUBLFOOD

Lupin ties up with Scope Opthalmics to market eyecare products in Mexico

LUPIN

GLAND

Stock market update: FMCG stocks down as market falls

The 30-share BSE Sensex closed down 1272.07 points at 84299.78

BSE

Stock market update: Stocks that hit 52-week lows on NSE in today's trade

Hero MotoCorp, Trent, RIL, Axis Bank and BEL were among the top losers on NSE in today's trade.

Gainers & Losers: Reliance Industries, Tata Motors among 12 stocks in limelight on Monday

Indian benchmark equity indices fell sharply on Monday, with the Sensex dropping nearly 1,300 points and the Nifty slipping near the 25,800 mark, amid mixed cues from regional markets.

RELIANCE

TATAMOTORS

NMDC, Dalmia Bharat among 5 stocks with long buildup

undefined

NMDC

DALBHARAT

Buy Adani Energy Solutions, target price Rs 1,318: ICICI Securities

ICICI Securities has buy call on Adani Energy Solutions with a target price of Rs 1,318. The current market price of Adani Energy Solutions is Rs 1,010.2.

ADANIENSOL

ISEC

BEL shares drop 1.96% as Sensex falls

On the technical charts, the RSI of the stock stood at 46.02.

BEL

Britannia Industries among 5 stocks with consistently High ROE

Five Nifty 50 companies (Nestle, Britannia, Coal India, TCS, Infosys) show consistent ROE improvement over four years, indicating strong profitability and management efficiency.

HDFC AMC shares down 2.44% as Sensex falls

A total of 8,585 shares changed hands on the counter till 01:53PM (IST)

TOTAL

GAIL shares up 2.55% as Nifty drops

A total of 663,062 shares changed hands on the counter till time (IST).

GAIL

TOTAL

REC shares up 0.16% as Nifty drops

A total of 193,656 shares changed hands on the counter till time (IST).

RECLTD

TOTAL

Nestle India among 5 stocks with consistently High ROCE

Among the Nifty 50 stocks, five companies have significantly improved their ROCE, showing increases for four consecutive fiscal years from FY21 to FY24.

NESTLEIND

Vakrangee Ltd leads gainers in 'A' group

Saregama India Ltd, Bombay Dyeing & Manufacturing Company Ltd, Sequent Scientific Ltd and Astrazeneca Pharma India Ltd are among the other gainers in the BSE's 'A' group today, 30 September 2024.

This smallcap stock jumped 9% on its first data centre order win; details

Bajel Projects shares rose after the company announced that it has secured its first order for data centres.

BAJEL

Angel One, 5Paisa, IIFL Securities shares to be in focus today — Here's why

While, NSE came out with new transaction charges for cash and derivatives segments, BSE announced changes for Sensex and Bankex options contracts of the equity derivatives segment.

Stocks to Watch: IDFC First Bank, PNB, Dr Reddy's, REC, RIL, Welspun Enterprises, Biocon, and more

Here’s a quick look at stocks likely to be in focus in today's trade.

Marketbuzz Podcast with Hormaz Fatakia: Important week ahead for Nifty; BSE, Angel One may react

Marketbuzz Podcast: Indian markets may see a slightly negative start according to the GIFT Nifty. Watch out for stocks like BSE, Pharma names like Biocon and Welspun Corp.

Israel-Hezbollah war impacts global stock markets: Asia shares dragged by Nikkei, China keeps rallying

The Shanghai Composite rose 4.4%. Geopolitical uncertainties and upcoming U.S. economic data could influence market direction.

GLOBAL

Breakout stocks to buy or sell: Shree Renuka Sugars to Rolex Rings — Sumeet Bagadia recommends three stocks to buy today

Breakout stocks to buy or sell: Sumeet Bagadia recommends three stocks to buy today — SeQuent Scientific, Rolex Rings, DentalKart or Vasa Denticity, Shree Renuka Sugars, and LMW

China property shares soar after big cities ease homebuying

A Bloomberg gauge of Chinese property stocks jumped as much as 14% on Monday morning after Shanghai, Shenzhen and Guangzhou relaxed homebuying curbs. The central bank on Sunday also said it will allow refinancing of mortgages.

CENTRALBK

Stock Market Highlights: Nifty, Sensex record biggest losses in two months amid broad-based selling

Sensex Today | Stock Market Highlights: The Sensex plummeted by 1,272 points to close at 84,300, while the Nifty dropped 368 points, finishing at 25,811. Heavyweights including Reliance Industries (RIL), ICICI Bank, HDFC Bank, and Axis Bank were the biggest drags on the Nifty, contributing significantly to the fall.

Buy or sell: Vaishali Parekh recommends three stocks to buy today — September 30

Buy or sell stocks: Vaishali Parekh has recommended three stocks to buy today — ONGC, NLC India, and Bharat Dynamics 

Burman family calls for ouster of Care Health chair amid ED probe

The move comes ahead of Care Health's annual shareholders' meeting, where Saluja's reappointment as a director is up for consideration. Religare owns close to 64% stake in Care

RELIGARE

M&A expert outlines four key drivers behind India's deal-making surge

Anu Aiyengar, Global Head of Advisory and Mergers & Acquisitions (M&A) at JPMorgan, said that the M&A market has doubled compared to the last decade, growing from an average of $70 billion to $140 billion.

M&M

GLOBAL

IPO rush: Hyundai, Swiggy, NTPC Green Energy among companies looking to raise ₹60,000 crore in Oct-Nov

The primary market will see more than half a dozen companies lining up IPOs over the next two months to raise around ₹60,000 crore

NTPC

Mark Zuckerberg now fourth richest in the world: Net worth crosses $200 billion, Orion glasses pay off Metaverse bet

The Orion glasses propelled Meta shares to a record high, supporting Mark Zuckerberg's Metaverse bet, which initially looked like a mistake

WORTH

The coming cola war: Can Reliance's Campa compete with Coca-Cola and PepsiCo?

Reliance Consumer Products has reintroduced Campa Cola with a new campaign and competitive pricing. The brand, now owned by Reliance, aims to disrupt the cola market dominated by Coca-Cola and PepsiCo. With strategic distribution and marketing plans, Campa Cola seeks to resonate with younger consumers and expand its presence in India.

RELIANCE

Movers & Shakers: Stocks that will see action this week

Here is what the charts say about the shares of Crest Ventures, Exide Industries and NMDC

NMDC

EXIDEIND

CREST

Zydus gets USFDA approval to produce its generic prostate cancer drug

Zydus Lifesciences on Saturday said it has received approval from the US health regulator to produce generic prostate cancer treatment drug. The company has received approval from the US Food and Drug Administration (USFDA) to manufacture Enzalutamide capsules (40 mg), it said in a regulatory filing. Enzalutamide capsules are androgen receptor inhibitors indicated for the treatment of patients with metastatic castration-resistant prostate cancer. The drug will be produced at the group's manufacturing site in Moraiya, Ahmedabad, Zydus said. As per IQVIA MAT July 2024 data, Enzalutamide capsules (40 mg) had annual sales of USD 869.4 million in the US. The group now has 400 approvals and has filed over 465 abbreviated new drug applications (ANDAs) since the commencement of the filing process in FY 2003-04.

ZYDUSLIFE

Tata Motors breaks ground for ₹9,000-cr high-end vehicle manufacturing unit in TN

The facility is expected to have an annual production capacity exceeding 2.5 lakh units, with production ramping up in phases to achieve this target over the next 5 to 7 years

TATAMOTORS

IPO Calendar: 3 new issues, 12 listings to keep primary market busy next week

The next few months are going to be exciting for investors with some big companies likely to hit the public markets. These include, Hyundai Motor, Swiggy, Waaree Energies, NTPC Green, NSE among others.

NTPC

Concurrent Gainers: Adani Ent, M&M among 11 stocks that gained for 5 days in a row

In this weekly rally, ETMarkets identified that 11 stocks from the BSE100 pack showed consistent price increases during this timeframe.

M&M

62 BSE500 stocks give double-digit returns in September as market scales record highs. What's next?

Benchmark Sensex rose 1.22% in September, as many as 62 stocks on BSE 500 clocked double-digit gains of up to 35%. Among these, about seven of them offered over 25% returns to investors during the month.

BSE

Sequent to absorb Viyash, giving 56 for 100 shares

In a stock exchange filing, Sequent Scientific said its board has approved a proposal to merge Viyash Life Sciences and its group companies, and its wholly owned subsidiary Sequent Research with it.

SEQUENT

UBS picks 2 pharma stocks that are likely to give 23-26% returns

Ascribing sell ratings to Lupin, Dr Reddy’s Laboratories, Zydus Lifesciences and Aurobindo Pharma, the brokerage said the US generic market has been declining and the pace could worsen.

IDFC to merge with IDFC FIRST Bank, effective October 1

IDFC Ltd will merge into IDFC First Bank effective October 1, following approval from the National Company Law Tribunal. The merger will dissolve IDFC financial holdings and simplify the corporate structure. IDFC First Bank will issue new equity shares and address accumulated losses, potentially enabling future dividend payments.

IDFCFIRSTB

IDFC

NSE and BSE revise their transaction fees to comply with Sebi circular

NSE revised the charges for the cash market to Rs 2.97 per side per lakh of traded value

BSE

Trent, Kotak Mahindra Bank among 5 stocks with short buildup

This suggests that a growing number of traders anticipate a price decline and are positioning themselves to profit from it by selling short.

KOTAKBANK

M&M

TRENT

PNB raises ₹5,000 crore via QIP to strengthen capital base

The QIP, which launched on September 23 and closed on September 26, received an overwhelming response from the market. Shares of Punjab National Bank ended at ₹109.25, up by ₹1.95, or 1.82%, on the BSE.

PNB

BSE

Sterling Wilson Renewable Energy promoters sell 7.14% stake for Rs 1,040 cr

Shapoorji Pallonji and Company and Khurshed Yazdi Daruvala, promoters of Sterling And Wilson Renewable Energy, on Friday divested a 7.14 per cent stake in the company for Rs 1,040 crore via open market transactions. According to the bulk deal data available with the NSE, Shapoorji Pallonji and Company Pvt Ltd offloaded 1.35 crore shares, amounting to a 5.78 per cent stake in Sterling And Wilson Renewable Energy (SWSOLAR). In addition, Khurshed Yazdi Daruvala sold 31.50 lakh shares or 1.35 per cent holding in solar EPC solutions provider Sterling And Wilson Renewable Energy. The shares were disposed of in the price range varying from Rs 623.28-630.01 apiece, taking the combined transaction value to Rs 1,039.88 crore. After the stake sale, Shapoorji Pallonji and Company's shareholding in SWSOLAR has declined to 6.95 per cent from 12.73 per cent, while Daruvala's stake has come down to 0.13 per cent from 1.48 per cent. Also, the combined shareholding of promoter and promoter group ha

SWSOLAR

NSE, BSE revise transaction fees: Here are new charges effective from October 1

BSE revised transaction charges for Sensex and Bankex options to ₹3,250 per crore effective October 1, 2024, per SEBI's directive.

BSE

Zomato co-founder & CPO Akriti Chopra resigns

Online food delivery platform Zomato Ltd's co-founder and chief people officer (CPO) Akriti Chopra resigns to pursue other interests, according to the company's Bombay Stock Exchange (BSE) filing on Friday, September 27.

ZOMATO

BSE

SJVN stock surges 5% following PSU agreement with Maharashtra government

The multibagger stock increased by 5.71 per cent to ₹133.20 in today's session on the BSE. The company's market capitalization is ₹52,266 crore. On the BSE, 21.35 lakh shares were traded, resulting in a turnover of ₹27.89 crore.

SJVN

BSE

ICICI Bank offers special deals on iPhone 16 and other Apple products

ICICI Bank has announced special offers for customers purchasing Apple products, including up to Rs 5,000 cashback on iPhone 16 purchases using credit cards and EMI options. Additional cashback is available on Apple Watch and AirPods. The offer is valid until December 31, 2024, and includes exclusive benefits for ICICI Bank credit card holders.

ICICIBANK

Stock market update: FMCG stocks down as market falls

The 30-share BSE Sensex closed down 264.27 points at 85571.85

BSE

Dividend, Bonus, Split: KPI Green Energy, 6 others to go ex-date next week

Here is the full list of stocks that will trade ex-date next for major corporate announcements, such as dividends, bonus issues, and subdivision:

KPIGREEN